On October 21, 2026, InnoBeam Technology, a frontrunner in China's liquid metal bearing CT tube technology sector, proudly declared the successful closure of its Series C market-oriented funding round, amassing over 200 million yuan. This significant funding milestone was co-led by esteemed funds from CICC Capital and Zhejiang Industrial Investment, with Shanxi Securities Innovation joining as a subsequent investor. Longstanding shareholders, including Hongchuang Capital, Daoyuan Capital, Bridge Capital, and Jiaxin InnoBeam, demonstrated their unwavering confidence by further augmenting their stakes. Capital Fortune played a pivotal role as the exclusive financial advisor throughout this process.
Armed with this substantial capital infusion, InnoBeam Technology is poised to fully immerse itself in the preparations for an Initial Public Offering (IPO). The newly acquired funds will be strategically allocated to scale up the automated production line dedicated to liquid metal bearing CT tubes, bolster investments in the research, development, and regulatory approval of new product pipelines, and expedite the establishment of overseas market channels along with localized service networks.